Man Group Portfolio holdings
AUM
$46.3B
1-Year Return
20.09%
This Quarter Return
+11.24%
1 Year Return
+20.09%
3 Year Return
+87.95%
5 Year Return
+152.77%
10 Year Return
–
AUM
$46.3B
AUM Growth
+$12.8B
(+38%)
Cap. Flow
+$8.74B
Cap. Flow
% of AUM
18.89%
Top 10 Holdings %
Top 10 Hldgs %
19.11%
Holding
2,222
New
289
Increased
833
Reduced
661
Closed
273
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$1.17B |
| 2 |
NVIDIA
NVDA
|
$547M |
| 3 |
Microsoft
MSFT
|
$453M |
| 4 |
Apple
AAPL
|
$422M |
| 5 |
Salesforce
CRM
|
$258M |
Top Sells
| 1 |
Walt Disney
DIS
|
$137M |
| 2 |
Booz Allen Hamilton
BAH
|
$111M |
| 3 |
Amphenol
APH
|
$102M |
| 4 |
Wingstop
WING
|
$102M |
| 5 |
Cisco
CSCO
|
$99.5M |
Sector Composition
| 1 | Technology | 27.11% |
| 2 | Healthcare | 11.64% |
| 3 | Consumer Discretionary | 11.57% |
| 4 | Financials | 11.55% |
| 5 | Industrials | 8.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Myriad Genetics
MYGN
$615M
| $200K | ﹤0.01% |
37,656
+911
| +2% | +$4.84K |
|
|
BCYC
1727
Bicycle Therapeutics
BCYC
$496M
| $199K | ﹤0.01% |
+28,675
| New | +$199K |
|
1728
Mitek Systems
MITK
$448M
| $199K | ﹤0.01% |
+20,063
| New | +$199K |
|
1729
UroGen Pharma
URGN
$873M
| $196K | ﹤0.01% |
+14,285
| New | +$196K |
|
1730
Butterfly Network
BFLY
$393M
| $193K | ﹤0.01% |
96,310
+16,919
| +21% | +$33.8K |
|
1731
National Research Corp
NRC
$355M
| $192K | ﹤0.01% |
11,430
-1,931
| -14% | -$32.4K |
|
1732
Immunome
IMNM
$916M
| $192K | ﹤0.01% |
20,614
-1,931
| -9% | -$18K |
|
1733
Quad
QUAD
$334M
| $190K | ﹤0.01% |
33,702
-6,551
| -16% | -$37K |
|
1734
BrightView Holdings
BV
$1.36B
| $185K | ﹤0.01% |
+11,115
| New | +$185K |
|
1735
American Vanguard Corp
AVD
$159M
| $180K | ﹤0.01% |
45,815
-2,945
| -6% | -$11.5K |
|
1736
Entravision Communication
EVC
$226M
| $180K | ﹤0.01% |
77,387
-12,374
| -14% | -$28.7K |
|
|
BRT
1737
BRT Apartments
BRT
$282M
| $178K | ﹤0.01% |
11,402
-5,136
| -31% | -$80.3K |
|
1738
Inspired Entertainment
INSE
$253M
| $174K | ﹤0.01% |
+21,241
| New | +$174K |
|
1739
AMC Networks
AMCX
$328M
| $173K | ﹤0.01% |
27,669
+1,735
| +7% | +$10.9K |
|
1740
Arcturus Therapeutics
ARCT
$485M
| $173K | ﹤0.01% |
13,264
-3,231
| -20% | -$42K |
|
1741
PLAYSTUDIOS Inc
MYPS
$122M
| $172K | ﹤0.01% |
130,978
-75,782
| -37% | -$99.3K |
|
1742
Vimeo
VMEO
$734M
| $169K | ﹤0.01% |
41,849
-76,737
| -65% | -$310K |
|
1743
Gannett
GCI
$629M
| $169K | ﹤0.01% |
47,071
-27,895
| -37% | -$99.9K |
|
1744
Cullinan Oncology
CGEM
$413M
| $168K | ﹤0.01% |
+22,341
| New | +$168K |
|
1745
Ironwood Pharmaceuticals
IRWD
$188M
| $168K | ﹤0.01% |
234,257
-99,461
| -30% | -$71.3K |
|
|
UNIT
1746
Uniti Group
UNIT
$1.59B
| $168K | ﹤0.01% |
38,825
-42,482
| -52% | -$184K |
|
1747
Monte Rosa Therapeutics
GLUE
$305M
| $164K | ﹤0.01% |
+36,391
| New | +$164K |
|
1748
Spyre Therapeutics
SYRE
$1.03B
| $162K | ﹤0.01% |
+10,843
| New | +$162K |
|
1749
Playtika
PLTK
$1.4B
| $162K | ﹤0.01% |
34,302
+21,377
| +165% | +$101K |
|
1750
Bumble
BMBL
$697M
| $156K | ﹤0.01% |
23,723
-118,661
| -83% | -$782K |
|